$11.1MSeries A, 12 January 2026
Funds nationwide deployment across oncology practices, health systems, specialty pharmacies and infusion networks.
- Amount
- $11.1M
- Stage
- Series A
- Announced
- 12 January 2026
- Lead
- Cencora Ventures
- Other investors
- Optum Ventures, Oncology Ventures, Z21 Ventures
- Use of funds
- Funds nationwide deployment across oncology practices, health systems, specialty pharmacies and infusion networks.
- Checked
- Announced by the company
- Sources
- RISA Labs Closes $11.1M Series A to Scale AI Operating System for Oncology Nationwide biospace.com
RISA Labs Closes $11.1M Series A to Scale AI Operating System for Oncology Nationwide theaiinsider.tech